+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paediatric Healthcare Market - Global Forecast 2026-2032- Product Image
Paediatric Healthcare Market - Global Forecast 2026-2032- Product Image
Sale

Paediatric Healthcare Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968855
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Paediatric Healthcare Market is projected to reach USD 131.38 Billion in 2026. It is expected to continue growing at a CAGR of 7.83%, reaching USD 209.29 Billion by 2032.

Paediatric healthcare is shifting from episodic treatment to integrated, preventive, and digitally enabled child health services. Demand is anchored in measurable needs: UNICEF reported 4.9 million under-five deaths in 2022, while WHO identifies neonatal complications, pneumonia, diarrhoea, malaria, injuries, and congenital conditions as persistent child health priorities.

Growth is also shaped by vaccination recovery, paediatric chronic disease management, behavioural health demand, and family-centred care models. For industry leaders, the paediatric healthcare market increasingly depends on access, outcomes, workforce capacity, reimbursement alignment, and trusted digital infrastructure.

Transformative Shifts in the Paediatric Healthcare Landscape

The paediatric care landscape is being reshaped by preventive health, outpatient migration, virtual care, genomics, home-based monitoring, and value-based reimbursement. WHO and UNICEF immunization data show that millions of children remain zero-dose or under-immunized, reinforcing the commercial and public health importance of vaccine delivery, primary care networks, and school-linked care.

At the same time, paediatric hospitals are treating more medically complex children who survive prematurity, congenital disorders, and cancer. This is driving demand for multidisciplinary care coordination, paediatric specialty capacity, remote patient monitoring, and interoperable records that follow children across settings.

Cumulative Impact of Artificial Intelligence in Paediatric Care

Artificial intelligence is creating cumulative impact across paediatric healthcare by improving triage, imaging interpretation, clinical documentation, population health analytics, vaccine outreach, and operational planning. AI-enabled tools can help clinicians identify deterioration earlier, personalize risk stratification, and reduce administrative burden when implemented with human oversight.

However, paediatric AI requires stricter validation because children differ physiologically from adults and many algorithms are trained on adult-heavy datasets. Leaders must prioritize explainability, equity testing, data privacy, paediatric-specific clinical trials, and regulator-aligned governance to prevent bias and ensure safe adoption.

Key Regional Insights Across Paediatric Healthcare Markets

Asia-Pacific combines the world’s largest child populations with uneven access to paediatric specialists, making scalable primary care, vaccines, neonatal care, and telehealth central growth drivers. China and India anchor service volume, while Japan, South Korea, Singapore, and Australia lead in advanced paediatric hospitals, digital health, and precision diagnostics. The region’s priorities align closely with WHO child survival goals, national immunization programs, and expanding public insurance coverage.

North America benefits from high healthcare spending, strong paediatric research networks, established neonatal and specialty care infrastructure, and rapid digital health adoption. Europe is shaped by universal coverage, health technology assessment, paediatric medicine regulation, and strict data protection requirements. Latin America is advancing immunization, maternal-child health, and primary care programs but continues to face access disparities between urban and rural populations.

The Middle East, led by GCC health-system investment, is expanding tertiary paediatric hospitals, digital health platforms, and specialty care capacity as part of broader health transformation strategies. Africa remains focused on reducing preventable child mortality, improving immunization coverage, strengthening neonatal and maternal care, and expanding trained workforce capacity, with WHO and UNICEF data continuing to highlight pneumonia, malaria, diarrhoea, and neonatal conditions as major child health priorities.

Key Group Insights for Paediatric Healthcare Strategy

ASEAN paediatric healthcare is defined by expanding universal health coverage, urban hospital modernization, and continued rural access gaps, creating demand for affordable diagnostics, immunization infrastructure, mobile care models, and community-based primary care. GCC countries are investing in tertiary paediatric facilities, medical travel capabilities, digital health platforms, and specialty workforce development under national transformation agendas.

The European Union emphasizes paediatric medicine regulation, pharmacovigilance, cross-border health data, evidence-based reimbursement, and equity in access to child health services. BRICS countries combine large birth cohorts with rising middle-class demand and public health priorities, making scalability, affordability, vaccine delivery, neonatal care, and specialist access essential. G7 markets lead in paediatric innovation, specialty pharmaceuticals, clinical research, digital health integration, and quality measurement, while NATO members increasingly emphasize health-system resilience, supply security, emergency preparedness, and continuity of care for children during crises.

Key Country Insights in Paediatric Healthcare

The United States leads in paediatric specialty care, biomedical research funding, neonatal intensive care, and digital health adoption, while Canada emphasizes universal access, child health equity, and rural or remote service delivery. Mexico and Brazil are expanding public child health coverage, vaccination programs, and maternal-child services but continue to face regional disparities in specialist access, diagnostics, and continuity of care.

The United Kingdom, Germany, France, Italy, and Spain combine strong immunization programs, established paediatric systems, and evidence-based reimbursement with pressure from workforce shortages, waiting lists, and budget constraints. Russia maintains broad paediatric infrastructure and immunization capacity but faces modernization, regional access, and technology integration challenges.

China and India represent the largest paediatric demand pools, with priorities spanning neonatal survival, vaccination, nutrition, infectious disease control, chronic disease management, and specialty care access. Japan, Australia, and South Korea show advanced paediatric quality systems, high digital readiness, and growing attention to child and adolescent mental health, while also managing budget pressures linked to demographic change and rising complexity of care.

Actionable Recommendations for Paediatric Healthcare Leaders

Industry leaders should prioritize paediatric-specific evidence generation, equitable access, and measurable outcomes. Investments should focus on vaccination reach, neonatal and maternal-child integration, mental health capacity, chronic disease management, rare disease pathways, and care coordination for medically complex children.

Commercial strategies should align with payer expectations for value, safety, and interoperability. Organizations should build paediatric AI governance, expand telehealth with in-person referral pathways, partner with schools and community providers, and localize product design for affordability, language, caregiver engagement, and regulatory requirements.

Research Methodology

This executive summary is grounded in secondary research from globally recognized public health and healthcare sources, including WHO, UNICEF, CDC, OECD, World Bank, national health agencies, and peer-reviewed paediatric literature. The analysis prioritizes verified indicators such as child mortality, immunization coverage, disease burden, healthcare spending, workforce capacity, access gaps, and regulatory direction.

Insights were synthesized through market segmentation, regional comparison, policy review, technology assessment, and demand-driver mapping. The methodology excludes unsupported claims and avoids market estimation, sizing, share, and forecasting, emphasizing reproducible, data-backed interpretation suitable for paediatric healthcare executives, investors, providers, policymakers, and digital health innovators.

Conclusion

Paediatric healthcare is entering a decisive phase in which prevention, digital transformation, specialty care, and health equity converge. The strongest opportunities are tied to proven child health needs, including immunization, neonatal survival, chronic disease management, adolescent mental health, rare disease care, and coordinated care for complex conditions.

Organizations that combine clinical credibility, paediatric-specific data, responsible AI, and regionally tailored access models will be best positioned to improve performance. Sustainable leadership will depend on improving outcomes for children while meeting payer, regulator, provider, and caregiver expectations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Paediatric Healthcare Market, by Product Type
7.1. Introduction
7.2. Medical Devices
7.2.1. Neonatal Care Devices
7.2.2. Surgical Instruments
7.2.3. Monitoring Devices
7.3. Pharmaceuticals
7.3.1. Vaccines
7.3.2. Nutritional Supplements & Vitamins
7.3.3. Antibiotics & Antivirals
8. Paediatric Healthcare Market, by Route Of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.3.1. Intramuscular
8.3.2. Intravenous
8.3.3. Subcutaneous
8.4. Topical
8.4.1. Dermatological
8.4.2. Nasal
8.4.3. Ophthalmic
8.5. Transdermal
9. Paediatric Healthcare Market, by Patient Age Group
9.1. Introduction
9.2. Neonates (0-28 days)
9.3. Infants (1 month-1 year)
9.4. Toddlers (1-3 years)
9.5. Children (4-12 years)
10. Paediatric Healthcare Market, by Type of Illness
10.1. Introduction
10.2. Acute Illnesses
10.3. Chronic Illnesses
11. Paediatric Healthcare Market, by Inidication
11.1. Introduction
11.2. Gastrointestinal Disorders
11.2.1. Diarrhea
11.2.2. Malabsorption
11.3. Genetic Disorders
11.4. Infectious Diseases
11.4.1. Bacterial Infections
11.4.2. Fungal Infections
11.4.3. Viral Infections
11.5. Neurological Disorders
11.5.1. ADHD
11.5.2. Cerebral Palsy
11.5.3. Epilepsy
11.6. Respiratory Disorders
11.6.1. Asthma
11.6.2. Bronchitis
11.6.3. Pneumonia
12. Paediatric Healthcare Market, by Delivery Mode
12.1. Introduction
12.2. Home Care
12.2.1. Conventional Home Visit
12.2.2. Telehealth
12.3. Inpatient
12.4. Outpatient
12.4.1. Ambulatory Surgery
12.4.2. Day Care
13. Paediatric Healthcare Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Paediatric Healthcare Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Paediatric Healthcare Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. AbbVie Inc.
17.3. Amgen Inc.
17.4. Aveanna Healthcare Holdings Inc.
17.5. Bayer AG
17.6. Becton, Dickinson and Company
17.7. BioMarin Pharmaceutical Inc.
17.8. Blueberry Pediatrics
17.9. Bobbie Baby, Inc.
17.10. Boston Scientific Corporation
17.11. Cipla Limited
17.12. Danone S.A.
17.13. Danone S.A.
17.14. Dr. Reddy's Laboratories Limited
17.15. Eli Lilly and Company
17.16. GlaxoSmithKline plc
17.17. Johnson & Johnson
17.18. KidsCare Home Health, LLC
17.19. Masimo Corporation
17.20. Medtronic plc
17.21. Nestlé S.A.
17.22. Novartis AG
17.23. Pfizer Inc.
17.24. Reckitt Benckiser Group plc
17.25. Roche Holding AG
17.26. Sanofi S.A.
17.27. Serum Institute of India Pvt. Ltd.
17.28. Takeda Pharmaceutical Company Limited
17.29. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL PAEDIATRIC HEALTHCARE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PAEDIATRIC HEALTHCARE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DERMATOLOGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DERMATOLOGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DERMATOLOGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NASAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NASAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NASAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DIARRHEA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DIARRHEA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DIARRHEA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL MALABSORPTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL MALABSORPTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL MALABSORPTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ADHD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ADHD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ADHD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL CEREBRAL PALSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CEREBRAL PALSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CEREBRAL PALSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ASTHMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ASTHMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ASTHMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL BRONCHITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BRONCHITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL BRONCHITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL PNEUMONIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL PNEUMONIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL PNEUMONIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL DAY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL DAY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL DAY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 202. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 205. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 206. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 207. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 208. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 209. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 210. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 211. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 212. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 213. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 214. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 215. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 216. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 217. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 218. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 231. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 232. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 235. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 236. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 237. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 239. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 240. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 241. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 242. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 243. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 244. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 245. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 246. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 247. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 248. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 249. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 250. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 251. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 252. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 257. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 258. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 259. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 260. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 261. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 262. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 263. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 264. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 265. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 266. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 267. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 268. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 269. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 270. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 271. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 274. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 275. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 276. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 277. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 278. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 279. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 280. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 281. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 282. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 283. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 284. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 285. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 286. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 287. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 305. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 306. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 307. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 308. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 309. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 310. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 311. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 312. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 313. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 314. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 315. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 316. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 317. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 318. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 319. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 320. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 321. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 322. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 323. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 324. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 325. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 326. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 327. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 328. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 329. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 330. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 331. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 332. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 333. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 334. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 335. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 336. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 337. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 338. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 339. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 340. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 341. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 342. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 343. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 344. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 345. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 346. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 347. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2017-2032 (USD MILLION)
TABLE 348. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2017-2032 (USD MILLION)
TABLE 349. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 350. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 351. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 352. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2017-2032 (USD MILLION)
TABLE 353. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 354. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 355. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 356. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 359. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES,

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Aveanna Healthcare Holdings Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • BioMarin Pharmaceutical Inc.
  • Blueberry Pediatrics
  • Bobbie Baby, Inc.
  • Boston Scientific Corporation
  • Cipla Limited
  • Danone S.A.
  • Danone S.A.
  • Dr. Reddy's Laboratories Limited
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KidsCare Home Health, LLC
  • Masimo Corporation
  • Medtronic plc
  • Nestlé S.A.
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 131.38 Billion
Forecasted Market Value ( USD ) by 2032 $ 209.29 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Paediatric Cardiology Market Outlook 2026-2034: Market Share, and Growth Analysis by Device Type (Transcatheter Heart Valves, Occlusion Devices, Atherectomy Devices, Catheters, Stents, Introducer Sheaths, Other Device Type), Surgical Procedures, Disease Indication, End User - Product Image

Paediatric Cardiology Market Outlook 2026-2034: Market Share, and Growth Analysis by Device Type (Transcatheter Heart Valves, Occlusion Devices, Atherectomy Devices, Catheters, Stents, Introducer Sheaths, Other Device Type), Surgical Procedures, Disease Indication, End User

  • Report
  • 160 Pages
  • Global
From
Disposable Medical Supplies Market - Global Forecast 2026-2032 - Product Image

Disposable Medical Supplies Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Smart Enteral Feeding Pumps Market - Global Forecast 2026-2032 - Product Image

Smart Enteral Feeding Pumps Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Smart Stethoscope Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Smart Stethoscope Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 200 Pages
  • Global
From
Growth Spurt Record Charts Global Market Report 2026 - Product Image

Growth Spurt Record Charts Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.